Areteia Therapeutics
Clinical trials sponsored by Areteia Therapeutics, explained in plain language.
-
New pill tested to tame severe asthma attacks
Disease control TerminatedThis study tested an oral medication called dexpramipexole for people with severe asthma that is not well-controlled by standard inhalers. Over 1,000 participants took either the drug or a placebo pill for one year to see if it reduced the number of serious asthma flare-ups. The …
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New pill tested to tame severe asthma attacks
Disease control TerminatedThis study tested an oral medication called dexpramipexole for people with severe asthma driven by high levels of a specific white blood cell (eosinophils). Over 650 participants took either the drug or a placebo pill for one year to see if it safely reduced the number of serious…
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Extended safety check for promising severe asthma treatment
Disease control TerminatedThis study aimed to check the long-term safety of an experimental drug called dexpramipexole for adults with severe eosinophilic asthma. It enrolled 509 participants who had already completed one of two earlier Phase 3 trials. The main goal was to monitor for side effects and cha…
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC